Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-16KRRO144Vincent Loic A plan to sell securities of Korro Bio, Inc. under Form 144MEDIUM
Vincent Loic A filed Form 144 to notify SEC of plan to sell 3418 units of Korro Bio, Inc. securities around 2026-06-16, with aggregate market value of $37,017.28. The total outstanding units is 14422571.0. The amount planned to be sold represents 0.02% of total outstanding units; ...
Micro CapBiotechnology
2026-06-16LGND144STEPHEN L. SABBA plan to sell securities of LIGAND PHARMACEUTICALS INCORPORATED under Form 144MEDIUM
STEPHEN L. SABBA filed Form 144 to notify SEC of plan to sell 2145 units of LIGAND PHARMACEUTICALS INCORPORATED securities around 2026-06-16, with aggregate market value of $544,830.00. The total outstanding units is 20041061.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transacti...
Mid CapBiotechnology
2026-06-16ONC144CHAN LEE plan to sell securities of BeOne Medicines Ltd. under Form 144MEDIUM
CHAN LEE filed Form 144 to notify SEC of plan to sell 590 units of BeOne Medicines Ltd. securities around 2026-06-16, with aggregate market value of $156,925.25. The total outstanding units is 54885669.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months inc...
Mega CapBiotechnology